![\"\"](\"https:\/\/www.fhysilicone.com\/wp-content\/uploads\/2026\/07\/Choosing-Pigments-for-Medical-LSRSafety-Stability-and-Regulatory-Requirements-1024x683.png\")
<\/figure>\n\n\n\nSpis tre\u015bci<\/h1>\n\n\n\n\n- Dlaczego wyb\u00f3r pigment\u00f3w do medycznego LSR ma znaczenie<\/li>\n\n\n\n
- Oznaczenie \u201eklasy medycznej\u201d nie oznacza powszechnej akceptacji<\/li>\n\n\n\n
- Zrozumienie ca\u0142ego systemu pigmentowego<\/li>\n\n\n\n
- Rodzaje pigment\u00f3w stosowanych w medycznym LSR<\/li>\n\n\n\n
- Kwestie zwi\u0105zane z bezpiecze\u0144stwem i biokompatybilno\u015bci\u0105<\/li>\n\n\n\n
- Charakterystyka chemiczna i substancje ekstrahowalne<\/li>\n\n\n\n
- Stabilno\u015b\u0107 po sterylizacji<\/li>\n\n\n\n
- Odporno\u015b\u0107 termiczna i stabilno\u015b\u0107 podczas przetwarzania<\/li>\n\n\n\n
- Wyb\u00f3r pigment\u00f3w do przezroczystych i nieprzezroczystych tworzyw LSR<\/li>\n\n\n\n
- St\u0119\u017cenie i rozproszenie barwnika<\/li>\n\n\n\n
- Kwestie regulacyjne w Stanach Zjednoczonych<\/li>\n\n\n\n
- Europejskie wymagania dotycz\u0105ce wyrob\u00f3w medycznych<\/li>\n\n\n\n
- Lista kontrolna dokumentacji dostawcy<\/li>\n\n\n\n
- Produkcja i kontrola zmian<\/li>\n\n\n\n
- Typowe b\u0142\u0119dy przy doborze pigment\u00f3w<\/li>\n\n\n\n
- Lista kontrolna zapytania ofertowego<\/li>\n\n\n\n
- Najcz\u0119\u015bciej zadawane pytania<\/li>\n\n\n\n
- Wnioski<\/li>\n<\/ol>\n\n\n\n
Dlaczego wyb\u00f3r pigment\u00f3w do medycznego LSR ma znaczenie<\/h1>\n\n\n\n
Kolor mo\u017ce pe\u0142ni\u0107 kilka funkcji w urz\u0105dzeniu medycznym, w tym:<\/p>\n\n\n\n
\n- Identyfikacja rozmiaru produktu<\/li>\n\n\n\n
- Kodowanie po\u0142\u0105cze\u0144<\/li>\n\n\n\n
- Orientacja element\u00f3w<\/li>\n\n\n\n
- Rozr\u00f3\u017cnienie rodzin urz\u0105dze\u0144<\/li>\n\n\n\n
- Zarz\u0105dzanie zapasami szpitalnymi<\/li>\n\n\n\n
- Rozpoznawalno\u015b\u0107 marki<\/li>\n\n\n\n
- Identyfikator procedury lub wniosku<\/li>\n\n\n\n
- Rozdzielenie element\u00f3w wielokrotnego u\u017cytku od element\u00f3w jednorazowych<\/li>\n<\/ul>\n\n\n\n
Poniewa\u017c kolor mo\u017ce pe\u0142ni\u0107 funkcj\u0119 u\u017cytkow\u0105, nieoczekiwana zmiana, problem z zanieczyszczeniem lub brak sp\u00f3jno\u015bci partii mog\u0105 mie\u0107 powa\u017cniejsze konsekwencje ni\u017c zwyk\u0142a wada kosmetyczna.<\/p>\n\n\n\n
Uk\u0142ad pigmentowy mo\u017ce wp\u0142ywa\u0107 na:<\/p>\n\n\n\n
\n- Bezpiecze\u0144stwo biologiczne<\/li>\n\n\n\n
- Substancje ekstrahowalne i wymywalne<\/li>\n\n\n\n
- Wyniki bada\u0144 cytotoksyczno\u015bci<\/li>\n\n\n\n
- Trwa\u0142o\u015b\u0107 koloru po sterylizacji<\/li>\n\n\n\n
- W\u0142a\u015bciwo\u015bci mechaniczne<\/li>\n\n\n\n
- Zachowanie zwi\u0105zane z wyleczeniem<\/li>\n\n\n\n
- Wygl\u0105d powierzchni<\/li>\n\n\n\n
- Przejrzysto\u015b\u0107<\/li>\n\n\n\n
- Powtarzalno\u015b\u0107 produkcji<\/li>\n\n\n\n
- Dokumentacja regulacyjna<\/li>\n<\/ul>\n\n\n\n
Z tego powodu dob\u00f3r pigmentu nale\u017cy rozpocz\u0105\u0107 ju\u017c na etapie opracowywania materia\u0142u, a nie dopiero po sfinalizowaniu projektu elementu.<\/p>\n\n\n\n
Oznaczenie \u201eklasy medycznej\u201d nie oznacza powszechnej akceptacji<\/h1>\n\n\n\n
Wyra\u017cenie \u201cpigment klasy medycznej\u201d jest cz\u0119sto u\u017cywane w dyskusjach handlowych, ale nie nale\u017cy go traktowa\u0107 jako automatycznego zatwierdzenia dla ka\u017cdego wyrobu medycznego.<\/p>\n\n\n\n
Barwnik, kt\u00f3ry nadaje si\u0119 do jednego zastosowania, mo\u017ce nie by\u0107 odpowiedni do innego, poniewa\u017c ocena wyrob\u00f3w medycznych zale\u017cy od takich czynnik\u00f3w, jak:<\/p>\n\n\n\n
\n- Rodzaj kontaktu z pacjentem<\/li>\n\n\n\n
- Czas trwania kontaktu<\/li>\n\n\n\n
- Tkanka kontaktowa<\/li>\n\n\n\n
- Geometria urz\u0105dzenia<\/li>\n\n\n\n
- St\u0119\u017cenie pigmentu<\/li>\n\n\n\n
- Metoda sterylizacji<\/li>\n\n\n\n
- Warunki przetwarzania<\/li>\n\n\n\n
- Rynek docelowy<\/li>\n\n\n\n
- Ca\u0142kowita ekspozycja na substancje chemiczne<\/li>\n<\/ul>\n\n\n\n
W ramach system\u00f3w oceny biokompatybilno\u015bci FDA urz\u0105dzenia klasyfikuje si\u0119 wed\u0142ug charakteru i czasu trwania kontaktu z organizmem. Czas trwania kontaktu zazwyczaj okre\u015bla si\u0119 jako ograniczony, przed\u0142u\u017cony lub d\u0142ugotrwa\u0142y\/sta\u0142y, a brane pod uwag\u0119 parametry biologiczne r\u00f3\u017cni\u0105 si\u0119 w zale\u017cno\u015bci od kategorii urz\u0105dzenia.<\/p>\n\n\n\n
W zwi\u0105zku z tym o\u015bwiadczenie dostawcy powinno stanowi\u0107 uzupe\u0142nienie \u2014 ale nie mo\u017ce zast\u0105pi\u0107 \u2014 w\u0142asnej, opartej na ocenie ryzyka oceny biologicznej przeprowadzonej przez producenta wyrobu.<\/p>\n\n\n\n
Zrozumienie ca\u0142ego systemu pigmentowego<\/h1>\n\n\n\n
Barwniki do medycznych wyrob\u00f3w z LSR s\u0105 zazwyczaj wytwarzane przy u\u017cyciu mieszanki pigmentowej lub pasty barwi\u0105cej opracowanej specjalnie do przetw\u00f3rstwa silikonu.<\/p>\n\n\n\n
Typowy system kolor\u00f3w mo\u017ce zawiera\u0107:<\/p>\n\n\n\n
\n- Jeden lub wi\u0119cej pigment\u00f3w<\/li>\n\n\n\n
- No\u015bnik kompatybilny z silikonem<\/li>\n\n\n\n
- \u015arodki wspomagaj\u0105ce dyspersj\u0119<\/li>\n\n\n\n
- Sk\u0142adniki stabilizuj\u0105ce<\/li>\n\n\n\n
- Wykrywanie pozosta\u0142o\u015bci po przetwarzaniu<\/li>\n<\/ul>\n\n\n\n
No\u015bnik odgrywa wa\u017cn\u0105 rol\u0119, poniewa\u017c pomaga w r\u00f3wnomiernym rozprowadzeniu pigmentu w ca\u0142ej masie LSR. Jednak ka\u017cdy dodatkowy sk\u0142adnik mo\u017ce potencjalnie wp\u0142yn\u0105\u0107 na profil chemiczny formowanego wyrobu.<\/p>\n\n\n\n
Producent powinien zatem dokona\u0107 oceny:<\/p>\n\n\n\n
\n- Podstawowy LSR<\/li>\n\n\n\n
- Sam pigment<\/li>\n\n\n\n
- No\u015bnik pigmentu<\/li>\n\n\n\n
- Zalecane st\u0119\u017cenie dawki<\/li>\n\n\n\n
- W pe\u0142ni wymieszana i utwardzona mieszanka<\/li>\n\n\n\n
- Wysterylizowany gotowy element<\/li>\n<\/ol>\n\n\n\n
Zazwyczaj to gotowy, barwiony produkt \u2014 a nie tylko poszczeg\u00f3lne surowce \u2014 stanowi najwa\u017cniejszy przedmiot ko\u0144cowej oceny biologicznej i w\u0142a\u015bciwo\u015bci u\u017cytkowych.<\/p>\n\n\n\n
Rodzaje pigment\u00f3w stosowanych w medycznym LSR<\/h1>\n\n\n\n
W systemach barwienia LSR przeznaczonych do zastosowa\u0144 medycznych mog\u0105 by\u0107 stosowane pigmenty nieorganiczne, pigmenty organiczne lub starannie dobrane kombinacje obu tych rodzaj\u00f3w.<\/p>\n\n\n\n
Pigmenty nieorganiczne<\/h2>\n\n\n\n
Pigmenty nieorganiczne s\u0105 cz\u0119sto wybierane, gdy istotne znaczenie maj\u0105 stabilno\u015b\u0107 termiczna, krycie oraz d\u0142ugotrwa\u0142a trwa\u0142o\u015b\u0107 koloru.<\/p>\n\n\n\n
Typowe przyk\u0142ady mog\u0105 obejmowa\u0107:<\/p>\n\n\n\n
\n- Dwutlenek tytanu<\/li>\n\n\n\n
- Tlenki \u017celaza<\/li>\n\n\n\n
- Niekt\u00f3re pigmenty na bazie chromu<\/li>\n\n\n\n
- Pigmenty ultramarynowe<\/li>\n\n\n\n
- Zatwierdzone systemy wykorzystuj\u0105ce sadz\u0119<\/li>\n<\/ul>\n\n\n\n
Do typowych zalet nale\u017c\u0105:<\/p>\n\n\n\n
\n- Dobra odporno\u015b\u0107 termiczna<\/li>\n\n\n\n
- Wysoka nieprzezroczysto\u015b\u0107<\/li>\n\n\n\n
- Dobra odporno\u015b\u0107 na dzia\u0142anie \u015bwiat\u0142a<\/li>\n\n\n\n
- Stosunkowo stabilna skuteczno\u015b\u0107 sterylizacji<\/li>\n<\/ul>\n\n\n\n
Mo\u017cliwe ograniczenia obejmuj\u0105:<\/p>\n\n\n\n
\n- Mniej wyraziste odcienie<\/li>\n\n\n\n
- Wi\u0119ksza nieprzezroczysto\u015b\u0107<\/li>\n\n\n\n
- Potencjalne zagro\u017cenia zwi\u0105zane z metalami ci\u0119\u017ckimi w zale\u017cno\u015bci od sk\u0142adu i czysto\u015bci<\/li>\n\n\n\n
- Ograniczona przydatno\u015b\u0107 do produkt\u00f3w przezroczystych<\/li>\n<\/ul>\n\n\n\n
Zawsze nale\u017cy zweryfikowa\u0107 konkretny sk\u0142ad chemiczny pigmentu oraz obowi\u0105zuj\u0105ce przepisy, a nie wyci\u0105ga\u0107 wnioski na podstawie og\u00f3lnej charakterystyki danej rodziny pigment\u00f3w.<\/p>\n\n\n\n
Pigmenty organiczne<\/h2>\n\n\n\n
Pigmenty organiczne pozwalaj\u0105 uzyska\u0107 ja\u015bniejsze i bardziej nasycone kolory.<\/p>\n\n\n\n
Do typowych zalet nale\u017c\u0105:<\/p>\n\n\n\n
\n- \u017bywe odcienie czerwieni, b\u0142\u0119kitu, zieleni i \u017c\u00f3\u0142ci<\/li>\n\n\n\n
- Wysoka zdolno\u015b\u0107 barwienia<\/li>\n\n\n\n
- Wi\u0119ksza elastyczno\u015b\u0107 w dopasowywaniu kolor\u00f3w<\/li>\n\n\n\n
- Mo\u017cliwo\u015b\u0107 zastosowania w przypadku odcieni p\u00f3\u0142przezroczystych<\/li>\n<\/ul>\n\n\n\n
Mo\u017cliwe ograniczenia obejmuj\u0105:<\/p>\n\n\n\n
\n- Wi\u0119ksza wra\u017cliwo\u015b\u0107 na ciep\u0142o<\/li>\n\n\n\n
- Mo\u017cliwe blakni\u0119cie barw po na\u015bwietlaniu<\/li>\n\n\n\n
- Wi\u0119ksza zale\u017cno\u015b\u0107 od sk\u0142adu preparatu<\/li>\n\n\n\n
- Ewentualne obawy zwi\u0105zane z migracj\u0105 lub ekstrakcj\u0105<\/li>\n\n\n\n
- Bardziej zauwa\u017calne r\u00f3\u017cnice mi\u0119dzy partiami<\/li>\n<\/ul>\n\n\n\n
Pigment organiczny nale\u017cy dobra\u0107 na podstawie udokumentowanych w\u0142a\u015bciwo\u015bci w konkretnej recepturze LSR oraz w \u015bwietle przewidywanego procesu sterylizacji.<\/p>\n\n\n\n
Kwestie zwi\u0105zane z bezpiecze\u0144stwem i biokompatybilno\u015bci\u0105<\/h1>\n\n\n\n
Biokompatybilno\u015b\u0107 nie jest w\u0142a\u015bciwo\u015bci\u0105 charakterystyczn\u0105 wy\u0142\u0105cznie dla nazwy pigmentu lub gatunku silikonu. Okre\u015bla ona zdolno\u015b\u0107 materia\u0142u, z kt\u00f3rego wykonano wyroby medyczne, do wywo\u0142ywania odpowiedniej reakcji organizmu w konkretnym zastosowaniu.<\/p>\n\n\n\n
Strategia oceny biologicznej powinna uwzgl\u0119dnia\u0107 gotowy wyr\u00f3b w ca\u0142o\u015bci, w tym zawarte w nim barwniki.<\/p>\n\n\n\n
W zale\u017cno\u015bci od kategorii urz\u0105dzenia potencjalne punkty ko\u0144cowe oceny mog\u0105 obejmowa\u0107:<\/p>\n\n\n\n
\n- Cytotoksyczno\u015b\u0107<\/li>\n\n\n\n
- Uczulenie<\/li>\n\n\n\n
- Podra\u017cnienie lub reakcja \u015br\u00f3dsk\u00f3rna<\/li>\n\n\n\n
- Ostra toksyczno\u015b\u0107 og\u00f3lnoustrojowa<\/li>\n\n\n\n
- Pirogenno\u015b\u0107 wywo\u0142ana przez materia\u0142<\/li>\n\n\n\n
- Toksyczno\u015b\u0107 podostra lub podprzewlek\u0142a<\/li>\n\n\n\n
- Genotoksyczno\u015b\u0107<\/li>\n\n\n\n
- Implantacja<\/li>\n\n\n\n
- Zgodno\u015b\u0107 krwi<\/li>\n\n\n\n
- Toksyczno\u015b\u0107 przewlek\u0142a<\/li>\n\n\n\n
- Rakotw\u00f3rczo\u015b\u0107<\/li>\n\n\n\n
- Toksyczno\u015b\u0107 reprodukcyjna i rozwojowa<\/li>\n<\/ul>\n\n\n\n
Nie ka\u017cde badanie jest wymagane w przypadku ka\u017cdego wyrobu. Ocena powinna opiera\u0107 si\u0119 na analizie ryzyka i by\u0107 dostosowana do rodzaju kontaktu z wyrobem, czasu trwania kontaktu, dost\u0119pnych informacji o materia\u0142ach oraz \u015bcie\u017cki regulacyjnej.<\/p>\n\n\n\n
Norma ISO 10993-1 okre\u015bla wymagania i wytyczne dotycz\u0105ce oceny biologicznej w ramach procesu zarz\u0105dzania ryzykiem. W wydaniu z 2025 r. po\u0142o\u017cono nacisk na ocen\u0119 biologiczn\u0105 jako cz\u0119\u015b\u0107 szerszych ram zarz\u0105dzania ryzykiem zwi\u0105zanym z wyrobami medycznymi.<\/p>\n\n\n\n
Norma ISO 10993-5 opisuje metody badania cytotoksyczno\u015bci in vitro z wykorzystaniem wyrob\u00f3w medycznych lub ekstrakt\u00f3w z wyrob\u00f3w medycznych maj\u0105cych kontakt z hodowanymi kom\u00f3rkami.<\/p>\n\n\n\n
Raport z bada\u0144 dostawcy pigment\u00f3w mo\u017ce okaza\u0107 si\u0119 przydatny, jednak nale\u017cy go dok\u0142adnie przeanalizowa\u0107 pod k\u0105tem:<\/p>\n\n\n\n
\n- Sprawdzona receptura<\/li>\n\n\n\n
- Zawarto\u015b\u0107 pigmentu<\/li>\n\n\n\n
- Warunki ekstrakcji<\/li>\n\n\n\n
- Metoda badawcza<\/li>\n\n\n\n
- Laboratorium badawcze<\/li>\n\n\n\n
- Data sporz\u0105dzenia raportu<\/li>\n\n\n\n
- Czy badanie dotyczy\u0142o pigmentu, mieszanki barwi\u0105cej czy gotowego produktu<\/li>\n\n\n\n
- Czy warunki te odzwierciedlaj\u0105 zamierzone przeznaczenie urz\u0105dzenia<\/li>\n<\/ul>\n\n\n\n
Charakterystyka chemiczna i substancje ekstrahowalne<\/h1>\n\n\n\n
Charakterystyka chemiczna pomaga zidentyfikowa\u0107 substancje, kt\u00f3re mog\u0105 uwalnia\u0107 si\u0119 z gotowego elementu medycznego.<\/p>\n\n\n\n
Substancje zwi\u0105zane z pigmentami mog\u0105 obejmowa\u0107:<\/p>\n\n\n\n
\n- Monomery resztkowe<\/li>\n\n\n\n
- Elementy no\u015bne<\/li>\n\n\n\n
- Metale \u015bladowe<\/li>\n\n\n\n
- Substancje pomocnicze w przetw\u00f3rstwie<\/li>\n\n\n\n
- Produkty rozk\u0142adu<\/li>\n\n\n\n
- Produkty uboczne reakcji<\/li>\n\n\n\n
- Substancje o niskiej masie cz\u0105steczkowej<\/li>\n\n\n\n
- Zanieczyszczenia powsta\u0142e podczas produkcji pigment\u00f3w<\/li>\n<\/ul>\n\n\n\n
W projekcie wytycznych FDA z wrze\u015bnia 2024 r. dotycz\u0105cych analizy chemicznej chemia analityczna zosta\u0142a opisana jako jedno z podej\u015b\u0107, z kt\u00f3rych producenci mog\u0105 korzysta\u0107 podczas opracowywania strategii oceny biokompatybilno\u015bci wyrob\u00f3w medycznych.<\/p>\n\n\n\n
W zale\u017cno\u015bci od stopnia zagro\u017cenia zwi\u0105zanego z danym urz\u0105dzeniem charakterystyka chemiczna mo\u017ce obejmowa\u0107 takie techniki, jak:<\/p>\n\n\n\n
\n- Chromatografia gazowa sprz\u0119\u017cona ze spektrometri\u0105 masow\u0105<\/li>\n\n\n\n
- Chromatografia cieczowa sprz\u0119\u017cona ze spektrometri\u0105 masow\u0105<\/li>\n\n\n\n
- Spektrometria masowa z plazm\u0105 sprz\u0119\u017con\u0105 indukcyjnie<\/li>\n\n\n\n
- Spektroskopia w podczerwieni z transformacj\u0105 Fouriera<\/li>\n\n\n\n
- Analiza pozosta\u0142o\u015bci nieulotnych<\/li>\n\n\n\n
- Analiza lotnych i p\u00f3\u0142lotnych zwi\u0105zk\u00f3w organicznych<\/li>\n<\/ul>\n\n\n\n
Odpowiednie warunki ekstrakcji powinny uwzgl\u0119dnia\u0107 materia\u0142y, z kt\u00f3rych wykonano wyr\u00f3b, warunki ekspozycji klinicznej oraz przeznaczenie wyrobu.<\/p>\n\n\n\n
W przypadku zastosowa\u0144 zwi\u0105zanych z d\u0142ugotrwa\u0142ym kontaktem ze sk\u00f3r\u0105 lub implantami samo stwierdzenie, \u017ce barwnik jest \u201cnietoksyczny\u201d, zazwyczaj nie wystarcza. Konieczne mo\u017ce by\u0107 przedstawienie bardziej szczeg\u00f3\u0142owych informacji dotycz\u0105cych sk\u0142adu chemicznego, zanieczyszcze\u0144 oraz nara\u017cenia.<\/p>\n\n\n\n
Metale ci\u0119\u017ckie i zanieczyszczenia pierwiastkowe<\/h1>\n\n\n\n
Przy wyborze materia\u0142\u00f3w barwionych nale\u017cy zwr\u00f3ci\u0107 szczeg\u00f3ln\u0105 uwag\u0119 na zawarto\u015b\u0107 metali ci\u0119\u017ckich.<\/p>\n\n\n\n
Dostawca powinien by\u0107 w stanie przedstawi\u0107 obowi\u0105zuj\u0105ce warto\u015bci graniczne lub wyniki bada\u0144 dotycz\u0105ce takich element\u00f3w, jak:<\/p>\n\n\n\n
\n- O\u0142\u00f3w<\/li>\n\n\n\n
- Kadm<\/li>\n\n\n\n
- Rt\u0119\u0107<\/li>\n\n\n\n
- Arsen<\/li>\n\n\n\n
- Chrom<\/li>\n\n\n\n
- Nikiel<\/li>\n\n\n\n
- Antymon<\/li>\n\n\n\n
- Kobalt<\/li>\n<\/ul>\n\n\n\n
Dok\u0142adne elementy i ograniczenia nale\u017cy okre\u015bli\u0107 zgodnie z:<\/p>\n\n\n\n
\n- Chemia pigment\u00f3w<\/li>\n\n\n\n
- Device application<\/li>\n\n\n\n
- Patient exposure<\/li>\n\n\n\n
- Rynek docelowy<\/li>\n\n\n\n
- Customer specifications<\/li>\n\n\n\n
- Chemical risk assessment<\/li>\n<\/ul>\n\n\n\n
A statement of compliance should identify the test method, detection limits and material tested wherever possible.<\/p>\n\n\n\n
Manufacturers should avoid assuming that all inorganic pigments contain unsafe metal levels or that all organic pigments are automatically free of elemental impurities. Supplier-specific data is more reliable than broad pigment classifications.<\/p>\n\n\n\n
Stabilno\u015b\u0107 po sterylizacji<\/h1>\n\n\n\n
Medical LSR pigments should be evaluated using the actual intended sterilization method.<\/p>\n\n\n\n
Common sterilization processes for medical devices include moist heat, radiation and ethylene oxide. FDA also recognizes additional methods used for different device types.<\/p>\n\n\n\n
Sterilization may affect:<\/p>\n\n\n\n
\n- Hue<\/li>\n\n\n\n
- Lekko\u015b\u0107<\/li>\n\n\n\n
- Saturation<\/li>\n\n\n\n
- Przejrzysto\u015b\u0107<\/li>\n\n\n\n
- Wygl\u0105d powierzchni<\/li>\n\n\n\n
- Chemia pigment\u00f3w<\/li>\n\n\n\n
- Silicone base color<\/li>\n\n\n\n
- W\u0142a\u015bciwo\u015bci mechaniczne<\/li>\n<\/ul>\n\n\n\n
EO Sterilization<\/h2>\n\n\n\n
Ethylene oxide is generally processed at lower temperatures than steam sterilization. Many LSR colors show limited visual change after EO, but testing is still necessary.<\/p>\n\n\n\n
Potential concerns include:<\/p>\n\n\n\n
\n- Humidity-related changes<\/li>\n\n\n\n
- Packaging interactions<\/li>\n\n\n\n
- Residual-related appearance changes<\/li>\n\n\n\n
- Temporary color shift before aeration<\/li>\n\n\n\n
- Differences after accelerated aging<\/li>\n<\/ul>\n\n\n\n
Evaluation should be completed after the required aeration or stabilization period.<\/p>\n\n\n\n
Napromieniowanie gamma<\/h2>\n\n\n\n
Gamma radiation can create free radicals and change both the pigment and silicone matrix.<\/p>\n\n\n\n
Mo\u017cliwe skutki to mi\u0119dzy innymi:<\/p>\n\n\n\n
\n- \u017b\u00f3\u0142kni\u0119cie<\/li>\n\n\n\n
- Blakni\u0119cie<\/li>\n\n\n\n
- Ciemnienie<\/li>\n\n\n\n
- Utrata nasycenia<\/li>\n\n\n\n
- Transparency changes<\/li>\n\n\n\n
- Delayed post-irradiation color development<\/li>\n<\/ul>\n\n\n\n
A formulation that appears acceptable immediately after irradiation may change during storage. Measurements should therefore be taken at defined intervals, not only immediately after exposure.<\/p>\n\n\n\n
Steam Sterilization<\/h2>\n\n\n\n
Steam sterilization exposes the material to heat, moisture and pressure.<\/p>\n\n\n\n
Potential effects include:<\/p>\n\n\n\n
\n- Ciemnienie<\/li>\n\n\n\n
- Wybielanie<\/li>\n\n\n\n
- Loss of gloss<\/li>\n\n\n\n
- Pigment degradation<\/li>\n\n\n\n
- Base-material yellowing<\/li>\n\n\n\n
- Progressive changes after repeated cycles<\/li>\n<\/ul>\n\n\n\n
Reusable devices should be evaluated after the maximum claimed number of reprocessing cycles or according to an appropriate validated test plan.<\/p>\n\n\n\n
Odporno\u015b\u0107 termiczna i stabilno\u015b\u0107 podczas przetwarzania<\/h1>\n\n\n\n
LSR is normally cured at elevated mold temperatures. The pigment must tolerate the complete molding and post-curing process.<\/p>\n\n\n\n
Important variables include:<\/p>\n\n\n\n
\n- Temperatura formy<\/li>\n\n\n\n
- Czas utwardzania<\/li>\n\n\n\n
- Post-curing temperature<\/li>\n\n\n\n
- Post-curing duration<\/li>\n\n\n\n
- Shear during mixing<\/li>\n\n\n\n
- Residence time<\/li>\n\n\n\n
- St\u0119\u017cenie pigmentu<\/li>\n<\/ul>\n\n\n\n
An unstable pigment may produce:<\/p>\n\n\n\n
\n- Color drift<\/li>\n\n\n\n
- Burn marks<\/li>\n\n\n\n
- Dark spots<\/li>\n\n\n\n
- S\u0142aba dyspersja<\/li>\n\n\n\n
- Uneven curing<\/li>\n\n\n\n
- Surface streaks<\/li>\n\n\n\n
- Differences between thick and thin areas<\/li>\n<\/ul>\n\n\n\n
The pigment should be evaluated under worst-case processing conditions, particularly when the product includes:<\/p>\n\n\n\n
\n- Thick sections<\/li>\n\n\n\n
- Long cure times<\/li>\n\n\n\n
- Extended post-curing<\/li>\n\n\n\n
- Multiple cavities<\/li>\n\n\n\n
- Hot-runner systems<\/li>\n\n\n\n
- High production volumes<\/li>\n<\/ul>\n\n\n\n
A laboratory color plaque molded under ideal conditions may not accurately predict the appearance of the final component.<\/p>\n\n\n\n
Wyb\u00f3r pigment\u00f3w do przezroczystych i nieprzezroczystych tworzyw LSR<\/h1>\n\n\n\nTransparent Medical LSR<\/h2>\n\n\n\n
Transparent or translucent products require pigments with:<\/p>\n\n\n\n
\n- Fine and uniform dispersion<\/li>\n\n\n\n
- Low particle agglomeration<\/li>\n\n\n\n
- Controlled haze<\/li>\n\n\n\n
- Consistent tint strength<\/li>\n\n\n\n
- Minimal effect on optical clarity<\/li>\n<\/ul>\n\n\n\n
Very small pigment-concentration differences may be visible in transparent components.<\/p>\n\n\n\n
Wall thickness also has a major influence. A transparent blue part may look pale in a 1 mm section but much darker in a 5 mm section.<\/p>\n\n\n\n
For this reason, color approval plaques should closely represent the thickness and surface finish of the actual product.<\/p>\n\n\n\n
Opaque Medical LSR<\/h2>\n\n\n\n
Opaque colors generally provide greater visual coverage and can reduce the visibility of small base-material differences.<\/p>\n\n\n\n
However, opacity does not eliminate the need to evaluate:<\/p>\n\n\n\n
\n- Pigment dispersion<\/li>\n\n\n\n
- Sp\u00f3jno\u015b\u0107 kolor\u00f3w<\/li>\n\n\n\n
- Wyko\u0144czenie powierzchni<\/li>\n\n\n\n
- Zachowanie zwi\u0105zane z wyleczeniem<\/li>\n\n\n\n
- Stabilno\u015b\u0107 po sterylizacji<\/li>\n\n\n\n
- Chemical safety<\/li>\n<\/ul>\n\n\n\n
White pigments and pastel formulations can be especially sensitive to contamination, base-material yellowing and radiation-induced color changes.<\/p>\n\n\n\n
St\u0119\u017cenie i rozproszenie barwnika<\/h1>\n\n\n\n
Pigment loading should be kept within the validated formulation range.<\/p>\n\n\n\n
Too little pigment may cause:<\/p>\n\n\n\n
\n- Weak color<\/li>\n\n\n\n
- Excessive transparency<\/li>\n\n\n\n
- Visible batch variation<\/li>\n\n\n\n
- Inconsistent identification<\/li>\n<\/ul>\n\n\n\n
Too much pigment may cause:<\/p>\n\n\n\n
\n- Unnecessary chemical exposure<\/li>\n\n\n\n
- Reduced transparency<\/li>\n\n\n\n
- Cure interference<\/li>\n\n\n\n
- Mechanical-property changes<\/li>\n\n\n\n
- Poor mixing<\/li>\n\n\n\n
- Cost increases<\/li>\n<\/ul>\n\n\n\n
The appropriate concentration depends on:<\/p>\n\n\n\n
\n- Pigment strength<\/li>\n\n\n\n
- Base LSR transparency<\/li>\n\n\n\n
- Product thickness<\/li>\n\n\n\n
- Target color<\/li>\n\n\n\n
- Tekstura powierzchni<\/li>\n\n\n\n
- Metoda sterylizacji<\/li>\n<\/ul>\n\n\n\n
Production equipment should be capable of accurately controlling the color addition ratio.<\/p>\n\n\n\n
Possible mixing methods include:<\/p>\n\n\n\n
\n- Metered pigment dosing<\/li>\n\n\n\n
- Pre-compounded colored LSR<\/li>\n\n\n\n
- Controlled static mixing<\/li>\n\n\n\n
- Validated manual premixing for limited applications<\/li>\n<\/ul>\n\n\n\n
Medical manufacturing generally benefits from closed, controlled dosing systems that reduce contamination and operator variation.<\/p>\n\n\n\n
Kwestie regulacyjne w Stanach Zjednoczonych<\/h1>\n\n\n\n
Under certain conditions, color additives used in medical devices are subject to the color-additive provisions of the United States Federal Food, Drug, and Cosmetic Act.<\/p>\n\n\n\n
FDA states that a device containing a color additive may be considered adulterated unless an applicable regulation is in effect listing that color additive for its intended use.<\/p>\n\n\n\n
FDA also maintains a summary of color additives listed for use in foods, drugs, cosmetics and medical devices. The agency notes that color additives used in certain body-contacting medical devices are subject to premarket approval requirements.<\/p>\n\n\n\n
Medical-device manufacturers should therefore determine:<\/p>\n\n\n\n
\n- Whether the color additive is subject to listing requirements<\/li>\n\n\n\n
- Whether it is listed for the intended device use<\/li>\n\n\n\n
- Whether certification requirements apply<\/li>\n\n\n\n
- Whether any use restrictions are specified<\/li>\n\n\n\n
- Whether the device contact conditions fall within the listing<\/li>\n\n\n\n
- Whether additional safety information is required<\/li>\n<\/ul>\n\n\n\n
A pigment being commonly used in the silicone industry does not automatically establish that it is permitted for a particular medical-device application.<\/p>\n\n\n\n
The regulatory review should be conducted by personnel familiar with the intended US submission and product classification.<\/p>\n\n\n\n
\n\n\n\nEuropejskie wymagania dotycz\u0105ce wyrob\u00f3w medycznych<\/h1>\n\n\n\n
Medical devices placed on the European Union market are governed by Regulation (EU) 2017\/745, commonly known as the Medical Device Regulation.<\/p>\n\n\n\n
The MDR establishes requirements relating to medical-device safety, performance, risk management, technical documentation and market access.<\/p>\n\n\n\n
For colored LSR components, the manufacturer should consider:<\/p>\n\n\n\n
\n- Material characterization<\/li>\n\n\n\n
- Bezpiecze\u0144stwo biologiczne<\/li>\n\n\n\n
- Chemical risks<\/li>\n\n\n\n
- Manufacturing residues<\/li>\n\n\n\n
- Produkty rozk\u0142adu<\/li>\n\n\n\n
- Sterilization effects<\/li>\n\n\n\n
- Supplier controls<\/li>\n\n\n\n
- Change management<\/li>\n\n\n\n
- Technical-documentation traceability<\/li>\n<\/ul>\n\n\n\n
The pigment should be included in the device\u2019s material and risk-management documentation where relevant.<\/p>\n\n\n\n
Compliance declarations such as RoHS or REACH may support supplier qualification, but they should not be treated as substitutes for medical-device biological evaluation.<\/p>\n\n\n\n
Lista kontrolna dokumentacji dostawcy<\/h1>\n\n\n\n
A qualified medical LSR pigment supplier should be able to provide an appropriate documentation package.<\/p>\n\n\n\n
Depending on the application, useful documents may include:<\/p>\n\n\n\n
Material Identification<\/h2>\n\n\n\n\n- Product name and grade<\/li>\n\n\n\n
- Pigment or color code<\/li>\n\n\n\n
- Carrier description<\/li>\n\n\n\n
- Recommended dosing range<\/li>\n\n\n\n
- Manufacturing location<\/li>\n\n\n\n
- Okres przydatno\u015bci do spo\u017cycia<\/li>\n\n\n\n
- Warunki przechowywania<\/li>\n<\/ul>\n\n\n\n
Composition and Safety<\/h2>\n\n\n\n\n- Safety Data Sheet<\/li>\n\n\n\n
- Technical Data Sheet<\/li>\n\n\n\n
- O\u015bwiadczenie dotycz\u0105ce substancji obj\u0119tych ograniczeniami<\/li>\n\n\n\n
- Heavy-metal information<\/li>\n\n\n\n
- Applicable color-additive status<\/li>\n\n\n\n
- Statement regarding intentionally added substances<\/li>\n\n\n\n
- Available chemical-characterization information<\/li>\n<\/ul>\n\n\n\n
Biological Evaluation Support<\/h2>\n\n\n\n\n- ISO 10993 test reports, if available<\/li>\n\n\n\n
- Cytotoxicity report<\/li>\n\n\n\n
- Sensitization and irritation information<\/li>\n\n\n\n
- Test-formulation identification<\/li>\n\n\n\n
- Warunki ekstrakcji<\/li>\n\n\n\n
- Laboratory accreditation information<\/li>\n<\/ul>\n\n\n\n
Regulatory Support<\/h2>\n\n\n\n\n- FDA color-additive information where applicable<\/li>\n\n\n\n
- EU regulatory statements<\/li>\n\n\n\n
- REACH declaration<\/li>\n\n\n\n
- RoHS declaration where relevant<\/li>\n\n\n\n
- Conflict-mineral or other customer-requested declarations<\/li>\n\n\n\n
- Animal-derived material statement<\/li>\n\n\n\n
- Latex statement<\/li>\n\n\n\n
- Phthalate statement<\/li>\n\n\n\n
- Bisphenol statement<\/li>\n<\/ul>\n\n\n\n
Manufacturing and Quality<\/h2>\n\n\n\n\n- Identyfikowalno\u015b\u0107 partii<\/li>\n\n\n\n
- Certificate of Analysis<\/li>\n\n\n\n
- Zasady dotycz\u0105ce powiadomie\u0144 o zmianach<\/li>\n\n\n\n
- Quality-management certification<\/li>\n\n\n\n
- Batch-consistency controls<\/li>\n\n\n\n
- Retention-sample policy<\/li>\n<\/ul>\n\n\n\n
The required documentation should be agreed upon before color validation begins.<\/p>\n\n\n\n
Produkcja i kontrola zmian<\/h1>\n\n\n\n
Once the pigment is approved, the formulation should be controlled as part of the device manufacturing process.<\/p>\n\n\n\n
Important controls include:<\/p>\n\n\n\n
\n- Approved supplier<\/li>\n\n\n\n
- Approved pigment grade<\/li>\n\n\n\n
- Approved color formula<\/li>\n\n\n\n
- Defined concentration range<\/li>\n\n\n\n
- Material lot traceability<\/li>\n\n\n\n
- Mixing instructions<\/li>\n\n\n\n
- Molding parameters<\/li>\n\n\n\n
- Sterilization conditions<\/li>\n\n\n\n
- Color acceptance limits<\/li>\n\n\n\n
- Retained golden sample<\/li>\n\n\n\n
- Instrumental color measurement<\/li>\n\n\n\n
- Documented change approval<\/li>\n<\/ul>\n\n\n\n
Changes that may require assessment or revalidation include:<\/p>\n\n\n\n
\n- Pigment supplier change<\/li>\n\n\n\n
- Pigment-manufacturing-site change<\/li>\n\n\n\n
- Carrier formulation change<\/li>\n\n\n\n
- Base LSR change<\/li>\n\n\n\n
- Pigment concentration change<\/li>\n\n\n\n
- New sterilization method<\/li>\n\n\n\n
- Radiation-dose change<\/li>\n\n\n\n
- Molding or post-curing change<\/li>\n\n\n\n
- Device geometry change<\/li>\n\n\n\n
- New target market<\/li>\n<\/ul>\n\n\n\n
Even when the visible color appears unchanged, a formulation change may affect the chemical or biological profile.<\/p>\n\n\n\n
Establishing Color Acceptance Criteria<\/h1>\n\n\n\n
Color approval should combine visual and instrumental evaluation.<\/p>\n\n\n\n
Common control methods include:<\/p>\n\n\n\n
\n- Approved physical golden sample<\/li>\n\n\n\n
- L*, a* and b* values<\/li>\n\n\n\n
- Delta E tolerance<\/li>\n\n\n\n
- D65 light source<\/li>\n\n\n\n
- Defined observation angle<\/li>\n\n\n\n
- Neutral inspection background<\/li>\n\n\n\n
- Surface-finish specification<\/li>\n\n\n\n
- Transparency or haze specification<\/li>\n\n\n\n
- Pre- and post-sterilization limits<\/li>\n<\/ul>\n\n\n\n
Acceptance criteria should be based on the product\u2019s function.<\/p>\n\n\n\n
A decorative external component may allow a wider color tolerance than a color-coded connector used to distinguish device sizes.<\/p>\n\n\n\n
The limit should be agreed upon before mass production instead of being decided after variation occurs.<\/p>\n\n\n\n
Typowe b\u0142\u0119dy przy doborze pigment\u00f3w<\/h1>\n\n\n\nSelecting by Pantone Number Alone<\/h2>\n\n\n\n
Pantone references are generally printed color standards. Silicone is a three-dimensional material with different gloss, transparency and light-transmission properties.<\/p>\n\n\n\n
A Pantone number should be treated as an initial target, followed by approval of a molded sample.<\/p>\n\n\n\n
Approving Only the Raw Color Paste<\/h2>\n\n\n\n
The pigment masterbatch may look different after mixing, molding, curing, post-curing and sterilization.<\/p>\n\n\n\n
Approval should be based on representative molded components.<\/p>\n\n\n\n
Relying Only on a Supplier\u2019s \u201cMedical Grade\u201d Statement<\/h2>\n\n\n\n
The term does not replace application-specific risk assessment, biological evaluation or regulatory review.<\/p>\n\n\n\n
Ignoring the Pigment Carrier<\/h2>\n\n\n\n
The carrier is part of the colored formulation and should be included in the material assessment.<\/p>\n\n\n\n
Skipping Sterilization Testing<\/h2>\n\n\n\n
A pre-sterilization match does not guarantee post-sterilization stability.<\/p>\n\n\n\n
Changing Suppliers Without Revalidation<\/h2>\n\n\n\n
Two pigments with the same visual shade may have different chemistries, impurity profiles and sterilization behavior.<\/p>\n\n\n\n
Using Consumer-Grade Color Paste for Prototype Samples<\/h2>\n\n\n\n
Early prototype materials can influence customer expectations. Switching to a medically supported pigment later may make the approved color difficult to reproduce.<\/p>\n\n\n\n
\n\n\n\nRecommended Pigment Selection Workflow<\/h1>\n\n\n\n
A practical workflow can be divided into nine stages.<\/p>\n\n\n\n
Stage 1: Define the Device Application<\/h2>\n\n\n\n
Potwierd\u017a:<\/p>\n\n\n\n
\n- Device function<\/li>\n\n\n\n
- Patient-contact type<\/li>\n\n\n\n
- Czas trwania kontaktu<\/li>\n\n\n\n
- Target markets<\/li>\n\n\n\n
- Proces sterylizacji<\/li>\n\n\n\n
- Reusable or single-use status<\/li>\n<\/ul>\n\n\n\n
Stage 2: Define the Color Requirement<\/h2>\n\n\n\n
Potwierd\u017a:<\/p>\n\n\n\n
\n- Pantone, RAL or physical standard<\/li>\n\n\n\n
- Transparent, translucent or opaque appearance<\/li>\n\n\n\n
- Wyko\u0144czenie powierzchni<\/li>\n\n\n\n
- Grubo\u015b\u0107 \u015bcianki produktu<\/li>\n\n\n\n
- Functional color-coding requirements<\/li>\n<\/ul>\n\n\n\n
Stage 3: Prequalify Pigment Suppliers<\/h2>\n\n\n\n
Review:<\/p>\n\n\n\n
\n- Medical-use experience<\/li>\n\n\n\n
- Documentation availability<\/li>\n\n\n\n
- Traceability<\/li>\n\n\n\n
- Change-notification practices<\/li>\n\n\n\n
- Regulatory support<\/li>\n<\/ul>\n\n\n\n
Stage 4: Review Composition and Risk Information<\/h2>\n\n\n\n
Evaluate:<\/p>\n\n\n\n
\n- Chemia pigment\u00f3w<\/li>\n\n\n\n
- Carrier system<\/li>\n\n\n\n
- Restricted substances<\/li>\n\n\n\n
- Heavy-metal data<\/li>\n\n\n\n
- Available biological-test information<\/li>\n<\/ul>\n\n\n\n
Stage 5: Develop Laboratory Formulations<\/h2>\n\n\n\n
Prepare multiple concentration levels and mold representative plaques or components.<\/p>\n\n\n\n
Stage 6: Evaluate Processing Performance<\/h2>\n\n\n\n
Potwierd\u017a:<\/p>\n\n\n\n
\n- Dispersion<\/li>\n\n\n\n
- Zachowanie zwi\u0105zane z wyleczeniem<\/li>\n\n\n\n
- Wygl\u0105d powierzchni<\/li>\n\n\n\n
- W\u0142a\u015bciwo\u015bci mechaniczne<\/li>\n\n\n\n
- Moldability<\/li>\n<\/ul>\n\n\n\n
Stage 7: Test Sterilization Stability<\/h2>\n\n\n\n
Use the intended EO, gamma, steam or other validated sterilization process.<\/p>\n\n\n\n
Stage 8: Complete Biological and Chemical Evaluation<\/h2>\n\n\n\n
Assess the finished colored formulation according to the medical-device risk-management plan.<\/p>\n\n\n\n
Stage 9: Approve and Lock the Production Formula<\/h2>\n\n\n\n
Establish:<\/p>\n\n\n\n
\n- Golden sample<\/li>\n\n\n\n
- Formula number<\/li>\n\n\n\n
- Supplier and material codes<\/li>\n\n\n\n
- Warto\u015bci graniczne kontroli<\/li>\n\n\n\n
- Change-control requirements<\/li>\n\n\n\n
- Traceability records<\/li>\n<\/ul>\n\n\n\n
\n\n\n\nMedical LSR Pigment RFQ Checklist<\/h1>\n\n\n\n
To receive an accurate pigment and molding recommendation, provide the following information:<\/p>\n\n\n\n
\n- Medical-device application<\/li>\n\n\n\n
- Part drawing or 3D model<\/li>\n\n\n\n
- Type of body contact<\/li>\n\n\n\n
- Czas trwania kontaktu<\/li>\n\n\n\n
- Silicone grade<\/li>\n\n\n\n
- Wymagania dotycz\u0105ce twardo\u015bci<\/li>\n\n\n\n
- Transparent, translucent or opaque appearance<\/li>\n\n\n\n
- Pantone, RAL or physical color sample<\/li>\n\n\n\n
- Grubo\u015b\u0107 \u015bcianki produktu<\/li>\n\n\n\n
- Tekstura powierzchni<\/li>\n\n\n\n
- Metoda sterylizacji<\/li>\n\n\n\n
- Sterilization dose or cycle<\/li>\n\n\n\n
- Number of reusable cycles<\/li>\n\n\n\n
- Target markets<\/li>\n\n\n\n
- Required biological evaluation<\/li>\n\n\n\n
- Restricted-substance requirements<\/li>\n\n\n\n
- Annual volume<\/li>\n\n\n\n
- Prototype quantity<\/li>\n\n\n\n
- Wymagania dotycz\u0105ce opakowa\u0144<\/li>\n\n\n\n
- Color measurement tolerance<\/li>\n\n\n\n
- Required quality documents<\/li>\n<\/ul>\n\n\n\n
A detailed RFQ helps the molding supplier identify pigment risks before tooling and validation expenses are incurred.<\/p>\n\n\n\n
\n\n\n\nNajcz\u0119\u015bciej zadawane pytania<\/h1>\n\n\n\nWhat is a medical-grade LSR pigment?<\/h2>\n\n\n\n
It is generally a pigment or color masterbatch formulated and documented for use in medical silicone applications. However, the term alone does not establish suitability for every device. The complete finished formulation must still be evaluated according to its intended use.<\/p>\n\n\n\n
Does an ISO 10993 report mean the pigment is approved for all medical devices?<\/h2>\n\n\n\n
No. The report applies to the tested material, concentration, extraction conditions and endpoints. Device-specific biological evaluation is still required.<\/p>\n\n\n\n
Can food-grade silicone pigments be used in medical LSR?<\/h2>\n\n\n\n
Food-contact documentation does not automatically demonstrate medical-device suitability. Medical applications may require different chemical, biological and regulatory evidence.<\/p>\n\n\n\n
Which pigments are best for gamma sterilization?<\/h2>\n\n\n\n
There is no universal pigment family that performs best in every color and formulation. Candidate pigments should be screened at the intended radiation dose and evaluated immediately and after storage.<\/p>\n\n\n\n
Can the same pigment be used for EO and steam sterilization?<\/h2>\n\n\n\n
Possibly, but performance should be validated under both processes. Steam introduces higher thermal and moisture stress than EO.<\/p>\n\n\n\n
Does pigment affect LSR curing?<\/h2>\n\n\n\n
Certain pigments, carriers, impurities or excessive concentrations can influence cure behavior. Cure testing should be included during formulation development.<\/p>\n\n\n\n
Why does the molded color differ from the Pantone card?<\/h2>\n\n\n\n
Silicone transparency, thickness, surface texture and lighting affect visual appearance. Pantone cards are printed references and cannot perfectly represent molded silicone.<\/p>\n\n\n\n
Should transparent medical LSR use less pigment?<\/h2>\n\n\n\n
Transparent formulations normally require carefully controlled, relatively low pigment levels, but the correct concentration depends on color strength, wall thickness and transparency requirements.<\/p>\n\n\n\n
Is a Certificate of Analysis required for every pigment batch?<\/h2>\n\n\n\n
This depends on the manufacturer\u2019s quality system and risk controls, but lot-specific documentation and traceability are strongly recommended for medical production.<\/p>\n\n\n\n
When should a colored LSR formulation be revalidated?<\/h2>\n\n\n\n
Revalidation or documented assessment may be needed after changes to the pigment, carrier, supplier, silicone grade, concentration, processing conditions, sterilization method or device design.<\/p>\n\n\n\n
\n\n\n\nWnioski<\/h1>\n\n\n\n
Choosing pigments for medical LSR requires more than achieving an attractive and accurate color.<\/p>\n\n\n\n
The selected pigment system must be compatible with the silicone, stable during molding and sterilization, supported by appropriate safety information and controlled through a documented medical-device quality process.<\/p>\n\n\n\n
Successful pigment selection begins with a clear understanding of the device application, patient-contact conditions and intended sterilization method. It continues through supplier qualification, formulation development, chemical and biological assessment, representative molding trials and post-sterilization evaluation.<\/p>\n\n\n\n
Manufacturers should avoid relying solely on broad terms such as \u201cmedical grade,\u201d \u201cFDA compliant\u201d or \u201cbiocompatible.\u201d These statements must be supported by documentation that is relevant to the specific formulation and intended device.<\/p>\n\n\n\n
By treating the pigment, carrier, silicone base, molding process and sterilization cycle as one complete material system, medical-device companies can achieve safer products, more consistent colors and a more efficient path from prototype development to validated mass production.<\/p>","protected":false},"excerpt":{"rendered":"
Selecting a pigment for medical liquid silicone rubber is not simply a matter of finding the closest Pantone color. The selected pigment system can affect the biological evaluation, chemical profile, sterilization stability, appearance and long-term consistency of the finished medical device. A pigment that performs well in a consumer silicone product may not provide the […]<\/p>\n","protected":false},"author":1,"featured_media":2594,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[33],"tags":[2221,2220,2008,2218,2009,2219,2222,1951,2217],"class_list":["post-2593","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technical-guides","tag-biocompatible-silicone-color","tag-lsr-color-matching","tag-medical-device-silicone","tag-medical-grade-silicone-pigment","tag-medical-liquid-silicone-rubber","tag-medical-lsr-pigments","tag-medical-silicone-colorants","tag-medical-silicone-molding","tag-sterilization-resistant-pigment"],"_links":{"self":[{"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/posts\/2593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/comments?post=2593"}],"version-history":[{"count":1,"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/posts\/2593\/revisions"}],"predecessor-version":[{"id":2595,"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/posts\/2593\/revisions\/2595"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/media\/2594"}],"wp:attachment":[{"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/media?parent=2593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/categories?post=2593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/tags?post=2593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Dlaczego wyb\u00f3r pigment\u00f3w do medycznego LSR ma znaczenie<\/h1>\n\n\n\n
Kolor mo\u017ce pe\u0142ni\u0107 kilka funkcji w urz\u0105dzeniu medycznym, w tym:<\/p>\n\n\n\n
- \n
- Identyfikacja rozmiaru produktu<\/li>\n\n\n\n
- Kodowanie po\u0142\u0105cze\u0144<\/li>\n\n\n\n
- Orientacja element\u00f3w<\/li>\n\n\n\n
- Rozr\u00f3\u017cnienie rodzin urz\u0105dze\u0144<\/li>\n\n\n\n
- Zarz\u0105dzanie zapasami szpitalnymi<\/li>\n\n\n\n
- Rozpoznawalno\u015b\u0107 marki<\/li>\n\n\n\n
- Identyfikator procedury lub wniosku<\/li>\n\n\n\n
- Rozdzielenie element\u00f3w wielokrotnego u\u017cytku od element\u00f3w jednorazowych<\/li>\n<\/ul>\n\n\n\n
Poniewa\u017c kolor mo\u017ce pe\u0142ni\u0107 funkcj\u0119 u\u017cytkow\u0105, nieoczekiwana zmiana, problem z zanieczyszczeniem lub brak sp\u00f3jno\u015bci partii mog\u0105 mie\u0107 powa\u017cniejsze konsekwencje ni\u017c zwyk\u0142a wada kosmetyczna.<\/p>\n\n\n\n
Uk\u0142ad pigmentowy mo\u017ce wp\u0142ywa\u0107 na:<\/p>\n\n\n\n
- \n
- Bezpiecze\u0144stwo biologiczne<\/li>\n\n\n\n
- Substancje ekstrahowalne i wymywalne<\/li>\n\n\n\n
- Wyniki bada\u0144 cytotoksyczno\u015bci<\/li>\n\n\n\n
- Trwa\u0142o\u015b\u0107 koloru po sterylizacji<\/li>\n\n\n\n
- W\u0142a\u015bciwo\u015bci mechaniczne<\/li>\n\n\n\n
- Zachowanie zwi\u0105zane z wyleczeniem<\/li>\n\n\n\n
- Wygl\u0105d powierzchni<\/li>\n\n\n\n
- Przejrzysto\u015b\u0107<\/li>\n\n\n\n
- Powtarzalno\u015b\u0107 produkcji<\/li>\n\n\n\n
- Dokumentacja regulacyjna<\/li>\n<\/ul>\n\n\n\n
Z tego powodu dob\u00f3r pigmentu nale\u017cy rozpocz\u0105\u0107 ju\u017c na etapie opracowywania materia\u0142u, a nie dopiero po sfinalizowaniu projektu elementu.<\/p>\n\n\n\n
Oznaczenie \u201eklasy medycznej\u201d nie oznacza powszechnej akceptacji<\/h1>\n\n\n\n
Wyra\u017cenie \u201cpigment klasy medycznej\u201d jest cz\u0119sto u\u017cywane w dyskusjach handlowych, ale nie nale\u017cy go traktowa\u0107 jako automatycznego zatwierdzenia dla ka\u017cdego wyrobu medycznego.<\/p>\n\n\n\n
Barwnik, kt\u00f3ry nadaje si\u0119 do jednego zastosowania, mo\u017ce nie by\u0107 odpowiedni do innego, poniewa\u017c ocena wyrob\u00f3w medycznych zale\u017cy od takich czynnik\u00f3w, jak:<\/p>\n\n\n\n
- \n
- Rodzaj kontaktu z pacjentem<\/li>\n\n\n\n
- Czas trwania kontaktu<\/li>\n\n\n\n
- Tkanka kontaktowa<\/li>\n\n\n\n
- Geometria urz\u0105dzenia<\/li>\n\n\n\n
- St\u0119\u017cenie pigmentu<\/li>\n\n\n\n
- Metoda sterylizacji<\/li>\n\n\n\n
- Warunki przetwarzania<\/li>\n\n\n\n
- Rynek docelowy<\/li>\n\n\n\n
- Ca\u0142kowita ekspozycja na substancje chemiczne<\/li>\n<\/ul>\n\n\n\n
W ramach system\u00f3w oceny biokompatybilno\u015bci FDA urz\u0105dzenia klasyfikuje si\u0119 wed\u0142ug charakteru i czasu trwania kontaktu z organizmem. Czas trwania kontaktu zazwyczaj okre\u015bla si\u0119 jako ograniczony, przed\u0142u\u017cony lub d\u0142ugotrwa\u0142y\/sta\u0142y, a brane pod uwag\u0119 parametry biologiczne r\u00f3\u017cni\u0105 si\u0119 w zale\u017cno\u015bci od kategorii urz\u0105dzenia.<\/p>\n\n\n\n
W zwi\u0105zku z tym o\u015bwiadczenie dostawcy powinno stanowi\u0107 uzupe\u0142nienie \u2014 ale nie mo\u017ce zast\u0105pi\u0107 \u2014 w\u0142asnej, opartej na ocenie ryzyka oceny biologicznej przeprowadzonej przez producenta wyrobu.<\/p>\n\n\n\n
Zrozumienie ca\u0142ego systemu pigmentowego<\/h1>\n\n\n\n
Barwniki do medycznych wyrob\u00f3w z LSR s\u0105 zazwyczaj wytwarzane przy u\u017cyciu mieszanki pigmentowej lub pasty barwi\u0105cej opracowanej specjalnie do przetw\u00f3rstwa silikonu.<\/p>\n\n\n\n
Typowy system kolor\u00f3w mo\u017ce zawiera\u0107:<\/p>\n\n\n\n
- \n
- Jeden lub wi\u0119cej pigment\u00f3w<\/li>\n\n\n\n
- No\u015bnik kompatybilny z silikonem<\/li>\n\n\n\n
- \u015arodki wspomagaj\u0105ce dyspersj\u0119<\/li>\n\n\n\n
- Sk\u0142adniki stabilizuj\u0105ce<\/li>\n\n\n\n
- Wykrywanie pozosta\u0142o\u015bci po przetwarzaniu<\/li>\n<\/ul>\n\n\n\n
No\u015bnik odgrywa wa\u017cn\u0105 rol\u0119, poniewa\u017c pomaga w r\u00f3wnomiernym rozprowadzeniu pigmentu w ca\u0142ej masie LSR. Jednak ka\u017cdy dodatkowy sk\u0142adnik mo\u017ce potencjalnie wp\u0142yn\u0105\u0107 na profil chemiczny formowanego wyrobu.<\/p>\n\n\n\n
Producent powinien zatem dokona\u0107 oceny:<\/p>\n\n\n\n
- \n
- Podstawowy LSR<\/li>\n\n\n\n
- Sam pigment<\/li>\n\n\n\n
- No\u015bnik pigmentu<\/li>\n\n\n\n
- Zalecane st\u0119\u017cenie dawki<\/li>\n\n\n\n
- W pe\u0142ni wymieszana i utwardzona mieszanka<\/li>\n\n\n\n
- Wysterylizowany gotowy element<\/li>\n<\/ol>\n\n\n\n
Zazwyczaj to gotowy, barwiony produkt \u2014 a nie tylko poszczeg\u00f3lne surowce \u2014 stanowi najwa\u017cniejszy przedmiot ko\u0144cowej oceny biologicznej i w\u0142a\u015bciwo\u015bci u\u017cytkowych.<\/p>\n\n\n\n
Rodzaje pigment\u00f3w stosowanych w medycznym LSR<\/h1>\n\n\n\n
W systemach barwienia LSR przeznaczonych do zastosowa\u0144 medycznych mog\u0105 by\u0107 stosowane pigmenty nieorganiczne, pigmenty organiczne lub starannie dobrane kombinacje obu tych rodzaj\u00f3w.<\/p>\n\n\n\n
Pigmenty nieorganiczne<\/h2>\n\n\n\n
Pigmenty nieorganiczne s\u0105 cz\u0119sto wybierane, gdy istotne znaczenie maj\u0105 stabilno\u015b\u0107 termiczna, krycie oraz d\u0142ugotrwa\u0142a trwa\u0142o\u015b\u0107 koloru.<\/p>\n\n\n\n
Typowe przyk\u0142ady mog\u0105 obejmowa\u0107:<\/p>\n\n\n\n
- \n
- Dwutlenek tytanu<\/li>\n\n\n\n
- Tlenki \u017celaza<\/li>\n\n\n\n
- Niekt\u00f3re pigmenty na bazie chromu<\/li>\n\n\n\n
- Pigmenty ultramarynowe<\/li>\n\n\n\n
- Zatwierdzone systemy wykorzystuj\u0105ce sadz\u0119<\/li>\n<\/ul>\n\n\n\n
Do typowych zalet nale\u017c\u0105:<\/p>\n\n\n\n
- \n
- Dobra odporno\u015b\u0107 termiczna<\/li>\n\n\n\n
- Wysoka nieprzezroczysto\u015b\u0107<\/li>\n\n\n\n
- Dobra odporno\u015b\u0107 na dzia\u0142anie \u015bwiat\u0142a<\/li>\n\n\n\n
- Stosunkowo stabilna skuteczno\u015b\u0107 sterylizacji<\/li>\n<\/ul>\n\n\n\n
Mo\u017cliwe ograniczenia obejmuj\u0105:<\/p>\n\n\n\n
- \n
- Mniej wyraziste odcienie<\/li>\n\n\n\n
- Wi\u0119ksza nieprzezroczysto\u015b\u0107<\/li>\n\n\n\n
- Potencjalne zagro\u017cenia zwi\u0105zane z metalami ci\u0119\u017ckimi w zale\u017cno\u015bci od sk\u0142adu i czysto\u015bci<\/li>\n\n\n\n
- Ograniczona przydatno\u015b\u0107 do produkt\u00f3w przezroczystych<\/li>\n<\/ul>\n\n\n\n
Zawsze nale\u017cy zweryfikowa\u0107 konkretny sk\u0142ad chemiczny pigmentu oraz obowi\u0105zuj\u0105ce przepisy, a nie wyci\u0105ga\u0107 wnioski na podstawie og\u00f3lnej charakterystyki danej rodziny pigment\u00f3w.<\/p>\n\n\n\n
Pigmenty organiczne<\/h2>\n\n\n\n
Pigmenty organiczne pozwalaj\u0105 uzyska\u0107 ja\u015bniejsze i bardziej nasycone kolory.<\/p>\n\n\n\n
Do typowych zalet nale\u017c\u0105:<\/p>\n\n\n\n
- \n
- \u017bywe odcienie czerwieni, b\u0142\u0119kitu, zieleni i \u017c\u00f3\u0142ci<\/li>\n\n\n\n
- Wysoka zdolno\u015b\u0107 barwienia<\/li>\n\n\n\n
- Wi\u0119ksza elastyczno\u015b\u0107 w dopasowywaniu kolor\u00f3w<\/li>\n\n\n\n
- Mo\u017cliwo\u015b\u0107 zastosowania w przypadku odcieni p\u00f3\u0142przezroczystych<\/li>\n<\/ul>\n\n\n\n
Mo\u017cliwe ograniczenia obejmuj\u0105:<\/p>\n\n\n\n
- \n
- Wi\u0119ksza wra\u017cliwo\u015b\u0107 na ciep\u0142o<\/li>\n\n\n\n
- Mo\u017cliwe blakni\u0119cie barw po na\u015bwietlaniu<\/li>\n\n\n\n
- Wi\u0119ksza zale\u017cno\u015b\u0107 od sk\u0142adu preparatu<\/li>\n\n\n\n
- Ewentualne obawy zwi\u0105zane z migracj\u0105 lub ekstrakcj\u0105<\/li>\n\n\n\n
- Bardziej zauwa\u017calne r\u00f3\u017cnice mi\u0119dzy partiami<\/li>\n<\/ul>\n\n\n\n
Pigment organiczny nale\u017cy dobra\u0107 na podstawie udokumentowanych w\u0142a\u015bciwo\u015bci w konkretnej recepturze LSR oraz w \u015bwietle przewidywanego procesu sterylizacji.<\/p>\n\n\n\n
Kwestie zwi\u0105zane z bezpiecze\u0144stwem i biokompatybilno\u015bci\u0105<\/h1>\n\n\n\n
Biokompatybilno\u015b\u0107 nie jest w\u0142a\u015bciwo\u015bci\u0105 charakterystyczn\u0105 wy\u0142\u0105cznie dla nazwy pigmentu lub gatunku silikonu. Okre\u015bla ona zdolno\u015b\u0107 materia\u0142u, z kt\u00f3rego wykonano wyroby medyczne, do wywo\u0142ywania odpowiedniej reakcji organizmu w konkretnym zastosowaniu.<\/p>\n\n\n\n
Strategia oceny biologicznej powinna uwzgl\u0119dnia\u0107 gotowy wyr\u00f3b w ca\u0142o\u015bci, w tym zawarte w nim barwniki.<\/p>\n\n\n\n
W zale\u017cno\u015bci od kategorii urz\u0105dzenia potencjalne punkty ko\u0144cowe oceny mog\u0105 obejmowa\u0107:<\/p>\n\n\n\n
- \n
- Cytotoksyczno\u015b\u0107<\/li>\n\n\n\n
- Uczulenie<\/li>\n\n\n\n
- Podra\u017cnienie lub reakcja \u015br\u00f3dsk\u00f3rna<\/li>\n\n\n\n
- Ostra toksyczno\u015b\u0107 og\u00f3lnoustrojowa<\/li>\n\n\n\n
- Pirogenno\u015b\u0107 wywo\u0142ana przez materia\u0142<\/li>\n\n\n\n
- Toksyczno\u015b\u0107 podostra lub podprzewlek\u0142a<\/li>\n\n\n\n
- Genotoksyczno\u015b\u0107<\/li>\n\n\n\n
- Implantacja<\/li>\n\n\n\n
- Zgodno\u015b\u0107 krwi<\/li>\n\n\n\n
- Toksyczno\u015b\u0107 przewlek\u0142a<\/li>\n\n\n\n
- Rakotw\u00f3rczo\u015b\u0107<\/li>\n\n\n\n
- Toksyczno\u015b\u0107 reprodukcyjna i rozwojowa<\/li>\n<\/ul>\n\n\n\n
Nie ka\u017cde badanie jest wymagane w przypadku ka\u017cdego wyrobu. Ocena powinna opiera\u0107 si\u0119 na analizie ryzyka i by\u0107 dostosowana do rodzaju kontaktu z wyrobem, czasu trwania kontaktu, dost\u0119pnych informacji o materia\u0142ach oraz \u015bcie\u017cki regulacyjnej.<\/p>\n\n\n\n
Norma ISO 10993-1 okre\u015bla wymagania i wytyczne dotycz\u0105ce oceny biologicznej w ramach procesu zarz\u0105dzania ryzykiem. W wydaniu z 2025 r. po\u0142o\u017cono nacisk na ocen\u0119 biologiczn\u0105 jako cz\u0119\u015b\u0107 szerszych ram zarz\u0105dzania ryzykiem zwi\u0105zanym z wyrobami medycznymi.<\/p>\n\n\n\n
Norma ISO 10993-5 opisuje metody badania cytotoksyczno\u015bci in vitro z wykorzystaniem wyrob\u00f3w medycznych lub ekstrakt\u00f3w z wyrob\u00f3w medycznych maj\u0105cych kontakt z hodowanymi kom\u00f3rkami.<\/p>\n\n\n\n
Raport z bada\u0144 dostawcy pigment\u00f3w mo\u017ce okaza\u0107 si\u0119 przydatny, jednak nale\u017cy go dok\u0142adnie przeanalizowa\u0107 pod k\u0105tem:<\/p>\n\n\n\n
- \n
- Sprawdzona receptura<\/li>\n\n\n\n
- Zawarto\u015b\u0107 pigmentu<\/li>\n\n\n\n
- Warunki ekstrakcji<\/li>\n\n\n\n
- Metoda badawcza<\/li>\n\n\n\n
- Laboratorium badawcze<\/li>\n\n\n\n
- Data sporz\u0105dzenia raportu<\/li>\n\n\n\n
- Czy badanie dotyczy\u0142o pigmentu, mieszanki barwi\u0105cej czy gotowego produktu<\/li>\n\n\n\n
- Czy warunki te odzwierciedlaj\u0105 zamierzone przeznaczenie urz\u0105dzenia<\/li>\n<\/ul>\n\n\n\n
Charakterystyka chemiczna i substancje ekstrahowalne<\/h1>\n\n\n\n
Charakterystyka chemiczna pomaga zidentyfikowa\u0107 substancje, kt\u00f3re mog\u0105 uwalnia\u0107 si\u0119 z gotowego elementu medycznego.<\/p>\n\n\n\n
Substancje zwi\u0105zane z pigmentami mog\u0105 obejmowa\u0107:<\/p>\n\n\n\n
- \n
- Monomery resztkowe<\/li>\n\n\n\n
- Elementy no\u015bne<\/li>\n\n\n\n
- Metale \u015bladowe<\/li>\n\n\n\n
- Substancje pomocnicze w przetw\u00f3rstwie<\/li>\n\n\n\n
- Produkty rozk\u0142adu<\/li>\n\n\n\n
- Produkty uboczne reakcji<\/li>\n\n\n\n
- Substancje o niskiej masie cz\u0105steczkowej<\/li>\n\n\n\n
- Zanieczyszczenia powsta\u0142e podczas produkcji pigment\u00f3w<\/li>\n<\/ul>\n\n\n\n
W projekcie wytycznych FDA z wrze\u015bnia 2024 r. dotycz\u0105cych analizy chemicznej chemia analityczna zosta\u0142a opisana jako jedno z podej\u015b\u0107, z kt\u00f3rych producenci mog\u0105 korzysta\u0107 podczas opracowywania strategii oceny biokompatybilno\u015bci wyrob\u00f3w medycznych.<\/p>\n\n\n\n
W zale\u017cno\u015bci od stopnia zagro\u017cenia zwi\u0105zanego z danym urz\u0105dzeniem charakterystyka chemiczna mo\u017ce obejmowa\u0107 takie techniki, jak:<\/p>\n\n\n\n
- \n
- Chromatografia gazowa sprz\u0119\u017cona ze spektrometri\u0105 masow\u0105<\/li>\n\n\n\n
- Chromatografia cieczowa sprz\u0119\u017cona ze spektrometri\u0105 masow\u0105<\/li>\n\n\n\n
- Spektrometria masowa z plazm\u0105 sprz\u0119\u017con\u0105 indukcyjnie<\/li>\n\n\n\n
- Spektroskopia w podczerwieni z transformacj\u0105 Fouriera<\/li>\n\n\n\n
- Analiza pozosta\u0142o\u015bci nieulotnych<\/li>\n\n\n\n
- Analiza lotnych i p\u00f3\u0142lotnych zwi\u0105zk\u00f3w organicznych<\/li>\n<\/ul>\n\n\n\n
Odpowiednie warunki ekstrakcji powinny uwzgl\u0119dnia\u0107 materia\u0142y, z kt\u00f3rych wykonano wyr\u00f3b, warunki ekspozycji klinicznej oraz przeznaczenie wyrobu.<\/p>\n\n\n\n
W przypadku zastosowa\u0144 zwi\u0105zanych z d\u0142ugotrwa\u0142ym kontaktem ze sk\u00f3r\u0105 lub implantami samo stwierdzenie, \u017ce barwnik jest \u201cnietoksyczny\u201d, zazwyczaj nie wystarcza. Konieczne mo\u017ce by\u0107 przedstawienie bardziej szczeg\u00f3\u0142owych informacji dotycz\u0105cych sk\u0142adu chemicznego, zanieczyszcze\u0144 oraz nara\u017cenia.<\/p>\n\n\n\n
Metale ci\u0119\u017ckie i zanieczyszczenia pierwiastkowe<\/h1>\n\n\n\n
Przy wyborze materia\u0142\u00f3w barwionych nale\u017cy zwr\u00f3ci\u0107 szczeg\u00f3ln\u0105 uwag\u0119 na zawarto\u015b\u0107 metali ci\u0119\u017ckich.<\/p>\n\n\n\n
Dostawca powinien by\u0107 w stanie przedstawi\u0107 obowi\u0105zuj\u0105ce warto\u015bci graniczne lub wyniki bada\u0144 dotycz\u0105ce takich element\u00f3w, jak:<\/p>\n\n\n\n
- \n
- O\u0142\u00f3w<\/li>\n\n\n\n
- Kadm<\/li>\n\n\n\n
- Rt\u0119\u0107<\/li>\n\n\n\n
- Arsen<\/li>\n\n\n\n
- Chrom<\/li>\n\n\n\n
- Nikiel<\/li>\n\n\n\n
- Antymon<\/li>\n\n\n\n
- Kobalt<\/li>\n<\/ul>\n\n\n\n
Dok\u0142adne elementy i ograniczenia nale\u017cy okre\u015bli\u0107 zgodnie z:<\/p>\n\n\n\n
- \n
- Chemia pigment\u00f3w<\/li>\n\n\n\n
- Device application<\/li>\n\n\n\n
- Patient exposure<\/li>\n\n\n\n
- Rynek docelowy<\/li>\n\n\n\n
- Customer specifications<\/li>\n\n\n\n
- Chemical risk assessment<\/li>\n<\/ul>\n\n\n\n
A statement of compliance should identify the test method, detection limits and material tested wherever possible.<\/p>\n\n\n\n
Manufacturers should avoid assuming that all inorganic pigments contain unsafe metal levels or that all organic pigments are automatically free of elemental impurities. Supplier-specific data is more reliable than broad pigment classifications.<\/p>\n\n\n\n
Stabilno\u015b\u0107 po sterylizacji<\/h1>\n\n\n\n
Medical LSR pigments should be evaluated using the actual intended sterilization method.<\/p>\n\n\n\n
Common sterilization processes for medical devices include moist heat, radiation and ethylene oxide. FDA also recognizes additional methods used for different device types.<\/p>\n\n\n\n
Sterilization may affect:<\/p>\n\n\n\n
- \n
- Hue<\/li>\n\n\n\n
- Lekko\u015b\u0107<\/li>\n\n\n\n
- Saturation<\/li>\n\n\n\n
- Przejrzysto\u015b\u0107<\/li>\n\n\n\n
- Wygl\u0105d powierzchni<\/li>\n\n\n\n
- Chemia pigment\u00f3w<\/li>\n\n\n\n
- Silicone base color<\/li>\n\n\n\n
- W\u0142a\u015bciwo\u015bci mechaniczne<\/li>\n<\/ul>\n\n\n\n
EO Sterilization<\/h2>\n\n\n\n
Ethylene oxide is generally processed at lower temperatures than steam sterilization. Many LSR colors show limited visual change after EO, but testing is still necessary.<\/p>\n\n\n\n
Potential concerns include:<\/p>\n\n\n\n
- \n
- Humidity-related changes<\/li>\n\n\n\n
- Packaging interactions<\/li>\n\n\n\n
- Residual-related appearance changes<\/li>\n\n\n\n
- Temporary color shift before aeration<\/li>\n\n\n\n
- Differences after accelerated aging<\/li>\n<\/ul>\n\n\n\n
Evaluation should be completed after the required aeration or stabilization period.<\/p>\n\n\n\n
Napromieniowanie gamma<\/h2>\n\n\n\n
Gamma radiation can create free radicals and change both the pigment and silicone matrix.<\/p>\n\n\n\n
Mo\u017cliwe skutki to mi\u0119dzy innymi:<\/p>\n\n\n\n
- \n
- \u017b\u00f3\u0142kni\u0119cie<\/li>\n\n\n\n
- Blakni\u0119cie<\/li>\n\n\n\n
- Ciemnienie<\/li>\n\n\n\n
- Utrata nasycenia<\/li>\n\n\n\n
- Transparency changes<\/li>\n\n\n\n
- Delayed post-irradiation color development<\/li>\n<\/ul>\n\n\n\n
A formulation that appears acceptable immediately after irradiation may change during storage. Measurements should therefore be taken at defined intervals, not only immediately after exposure.<\/p>\n\n\n\n
Steam Sterilization<\/h2>\n\n\n\n
Steam sterilization exposes the material to heat, moisture and pressure.<\/p>\n\n\n\n
Potential effects include:<\/p>\n\n\n\n
- \n
- Ciemnienie<\/li>\n\n\n\n
- Wybielanie<\/li>\n\n\n\n
- Loss of gloss<\/li>\n\n\n\n
- Pigment degradation<\/li>\n\n\n\n
- Base-material yellowing<\/li>\n\n\n\n
- Progressive changes after repeated cycles<\/li>\n<\/ul>\n\n\n\n
Reusable devices should be evaluated after the maximum claimed number of reprocessing cycles or according to an appropriate validated test plan.<\/p>\n\n\n\n
Odporno\u015b\u0107 termiczna i stabilno\u015b\u0107 podczas przetwarzania<\/h1>\n\n\n\n
LSR is normally cured at elevated mold temperatures. The pigment must tolerate the complete molding and post-curing process.<\/p>\n\n\n\n
Important variables include:<\/p>\n\n\n\n
- \n
- Temperatura formy<\/li>\n\n\n\n
- Czas utwardzania<\/li>\n\n\n\n
- Post-curing temperature<\/li>\n\n\n\n
- Post-curing duration<\/li>\n\n\n\n
- Shear during mixing<\/li>\n\n\n\n
- Residence time<\/li>\n\n\n\n
- St\u0119\u017cenie pigmentu<\/li>\n<\/ul>\n\n\n\n
An unstable pigment may produce:<\/p>\n\n\n\n
- \n
- Color drift<\/li>\n\n\n\n
- Burn marks<\/li>\n\n\n\n
- Dark spots<\/li>\n\n\n\n
- S\u0142aba dyspersja<\/li>\n\n\n\n
- Uneven curing<\/li>\n\n\n\n
- Surface streaks<\/li>\n\n\n\n
- Differences between thick and thin areas<\/li>\n<\/ul>\n\n\n\n
The pigment should be evaluated under worst-case processing conditions, particularly when the product includes:<\/p>\n\n\n\n
- \n
- Thick sections<\/li>\n\n\n\n
- Long cure times<\/li>\n\n\n\n
- Extended post-curing<\/li>\n\n\n\n
- Multiple cavities<\/li>\n\n\n\n
- Hot-runner systems<\/li>\n\n\n\n
- High production volumes<\/li>\n<\/ul>\n\n\n\n
A laboratory color plaque molded under ideal conditions may not accurately predict the appearance of the final component.<\/p>\n\n\n\n
Wyb\u00f3r pigment\u00f3w do przezroczystych i nieprzezroczystych tworzyw LSR<\/h1>\n\n\n\n
Transparent Medical LSR<\/h2>\n\n\n\n
Transparent or translucent products require pigments with:<\/p>\n\n\n\n
- \n
- Fine and uniform dispersion<\/li>\n\n\n\n
- Low particle agglomeration<\/li>\n\n\n\n
- Controlled haze<\/li>\n\n\n\n
- Consistent tint strength<\/li>\n\n\n\n
- Minimal effect on optical clarity<\/li>\n<\/ul>\n\n\n\n
Very small pigment-concentration differences may be visible in transparent components.<\/p>\n\n\n\n
Wall thickness also has a major influence. A transparent blue part may look pale in a 1 mm section but much darker in a 5 mm section.<\/p>\n\n\n\n
For this reason, color approval plaques should closely represent the thickness and surface finish of the actual product.<\/p>\n\n\n\n
Opaque Medical LSR<\/h2>\n\n\n\n
Opaque colors generally provide greater visual coverage and can reduce the visibility of small base-material differences.<\/p>\n\n\n\n
However, opacity does not eliminate the need to evaluate:<\/p>\n\n\n\n
- \n
- Pigment dispersion<\/li>\n\n\n\n
- Sp\u00f3jno\u015b\u0107 kolor\u00f3w<\/li>\n\n\n\n
- Wyko\u0144czenie powierzchni<\/li>\n\n\n\n
- Zachowanie zwi\u0105zane z wyleczeniem<\/li>\n\n\n\n
- Stabilno\u015b\u0107 po sterylizacji<\/li>\n\n\n\n
- Chemical safety<\/li>\n<\/ul>\n\n\n\n
White pigments and pastel formulations can be especially sensitive to contamination, base-material yellowing and radiation-induced color changes.<\/p>\n\n\n\n
St\u0119\u017cenie i rozproszenie barwnika<\/h1>\n\n\n\n
Pigment loading should be kept within the validated formulation range.<\/p>\n\n\n\n
Too little pigment may cause:<\/p>\n\n\n\n
- \n
- Weak color<\/li>\n\n\n\n
- Excessive transparency<\/li>\n\n\n\n
- Visible batch variation<\/li>\n\n\n\n
- Inconsistent identification<\/li>\n<\/ul>\n\n\n\n
Too much pigment may cause:<\/p>\n\n\n\n
- \n
- Unnecessary chemical exposure<\/li>\n\n\n\n
- Reduced transparency<\/li>\n\n\n\n
- Cure interference<\/li>\n\n\n\n
- Mechanical-property changes<\/li>\n\n\n\n
- Poor mixing<\/li>\n\n\n\n
- Cost increases<\/li>\n<\/ul>\n\n\n\n
The appropriate concentration depends on:<\/p>\n\n\n\n
- \n
- Pigment strength<\/li>\n\n\n\n
- Base LSR transparency<\/li>\n\n\n\n
- Product thickness<\/li>\n\n\n\n
- Target color<\/li>\n\n\n\n
- Tekstura powierzchni<\/li>\n\n\n\n
- Metoda sterylizacji<\/li>\n<\/ul>\n\n\n\n
Production equipment should be capable of accurately controlling the color addition ratio.<\/p>\n\n\n\n
Possible mixing methods include:<\/p>\n\n\n\n
- \n
- Metered pigment dosing<\/li>\n\n\n\n
- Pre-compounded colored LSR<\/li>\n\n\n\n
- Controlled static mixing<\/li>\n\n\n\n
- Validated manual premixing for limited applications<\/li>\n<\/ul>\n\n\n\n
Medical manufacturing generally benefits from closed, controlled dosing systems that reduce contamination and operator variation.<\/p>\n\n\n\n
Kwestie regulacyjne w Stanach Zjednoczonych<\/h1>\n\n\n\n
Under certain conditions, color additives used in medical devices are subject to the color-additive provisions of the United States Federal Food, Drug, and Cosmetic Act.<\/p>\n\n\n\n
FDA states that a device containing a color additive may be considered adulterated unless an applicable regulation is in effect listing that color additive for its intended use.<\/p>\n\n\n\n
FDA also maintains a summary of color additives listed for use in foods, drugs, cosmetics and medical devices. The agency notes that color additives used in certain body-contacting medical devices are subject to premarket approval requirements.<\/p>\n\n\n\n
Medical-device manufacturers should therefore determine:<\/p>\n\n\n\n
- \n
- Whether the color additive is subject to listing requirements<\/li>\n\n\n\n
- Whether it is listed for the intended device use<\/li>\n\n\n\n
- Whether certification requirements apply<\/li>\n\n\n\n
- Whether any use restrictions are specified<\/li>\n\n\n\n
- Whether the device contact conditions fall within the listing<\/li>\n\n\n\n
- Whether additional safety information is required<\/li>\n<\/ul>\n\n\n\n
A pigment being commonly used in the silicone industry does not automatically establish that it is permitted for a particular medical-device application.<\/p>\n\n\n\n
The regulatory review should be conducted by personnel familiar with the intended US submission and product classification.<\/p>\n\n\n\n
\n\n\n\nEuropejskie wymagania dotycz\u0105ce wyrob\u00f3w medycznych<\/h1>\n\n\n\n
Medical devices placed on the European Union market are governed by Regulation (EU) 2017\/745, commonly known as the Medical Device Regulation.<\/p>\n\n\n\n
The MDR establishes requirements relating to medical-device safety, performance, risk management, technical documentation and market access.<\/p>\n\n\n\n
For colored LSR components, the manufacturer should consider:<\/p>\n\n\n\n
- \n
- Material characterization<\/li>\n\n\n\n
- Bezpiecze\u0144stwo biologiczne<\/li>\n\n\n\n
- Chemical risks<\/li>\n\n\n\n
- Manufacturing residues<\/li>\n\n\n\n
- Produkty rozk\u0142adu<\/li>\n\n\n\n
- Sterilization effects<\/li>\n\n\n\n
- Supplier controls<\/li>\n\n\n\n
- Change management<\/li>\n\n\n\n
- Technical-documentation traceability<\/li>\n<\/ul>\n\n\n\n
The pigment should be included in the device\u2019s material and risk-management documentation where relevant.<\/p>\n\n\n\n
Compliance declarations such as RoHS or REACH may support supplier qualification, but they should not be treated as substitutes for medical-device biological evaluation.<\/p>\n\n\n\n
Lista kontrolna dokumentacji dostawcy<\/h1>\n\n\n\n
A qualified medical LSR pigment supplier should be able to provide an appropriate documentation package.<\/p>\n\n\n\n
Depending on the application, useful documents may include:<\/p>\n\n\n\n
Material Identification<\/h2>\n\n\n\n
- \n
- Product name and grade<\/li>\n\n\n\n
- Pigment or color code<\/li>\n\n\n\n
- Carrier description<\/li>\n\n\n\n
- Recommended dosing range<\/li>\n\n\n\n
- Manufacturing location<\/li>\n\n\n\n
- Okres przydatno\u015bci do spo\u017cycia<\/li>\n\n\n\n
- Warunki przechowywania<\/li>\n<\/ul>\n\n\n\n
Composition and Safety<\/h2>\n\n\n\n
- \n
- Safety Data Sheet<\/li>\n\n\n\n
- Technical Data Sheet<\/li>\n\n\n\n
- O\u015bwiadczenie dotycz\u0105ce substancji obj\u0119tych ograniczeniami<\/li>\n\n\n\n
- Heavy-metal information<\/li>\n\n\n\n
- Applicable color-additive status<\/li>\n\n\n\n
- Statement regarding intentionally added substances<\/li>\n\n\n\n
- Available chemical-characterization information<\/li>\n<\/ul>\n\n\n\n
Biological Evaluation Support<\/h2>\n\n\n\n
- \n
- ISO 10993 test reports, if available<\/li>\n\n\n\n
- Cytotoxicity report<\/li>\n\n\n\n
- Sensitization and irritation information<\/li>\n\n\n\n
- Test-formulation identification<\/li>\n\n\n\n
- Warunki ekstrakcji<\/li>\n\n\n\n
- Laboratory accreditation information<\/li>\n<\/ul>\n\n\n\n
Regulatory Support<\/h2>\n\n\n\n
- \n
- FDA color-additive information where applicable<\/li>\n\n\n\n
- EU regulatory statements<\/li>\n\n\n\n
- REACH declaration<\/li>\n\n\n\n
- RoHS declaration where relevant<\/li>\n\n\n\n
- Conflict-mineral or other customer-requested declarations<\/li>\n\n\n\n
- Animal-derived material statement<\/li>\n\n\n\n
- Latex statement<\/li>\n\n\n\n
- Phthalate statement<\/li>\n\n\n\n
- Bisphenol statement<\/li>\n<\/ul>\n\n\n\n
Manufacturing and Quality<\/h2>\n\n\n\n
- \n
- Identyfikowalno\u015b\u0107 partii<\/li>\n\n\n\n
- Certificate of Analysis<\/li>\n\n\n\n
- Zasady dotycz\u0105ce powiadomie\u0144 o zmianach<\/li>\n\n\n\n
- Quality-management certification<\/li>\n\n\n\n
- Batch-consistency controls<\/li>\n\n\n\n
- Retention-sample policy<\/li>\n<\/ul>\n\n\n\n
The required documentation should be agreed upon before color validation begins.<\/p>\n\n\n\n
Produkcja i kontrola zmian<\/h1>\n\n\n\n
Once the pigment is approved, the formulation should be controlled as part of the device manufacturing process.<\/p>\n\n\n\n
Important controls include:<\/p>\n\n\n\n
- \n
- Approved supplier<\/li>\n\n\n\n
- Approved pigment grade<\/li>\n\n\n\n
- Approved color formula<\/li>\n\n\n\n
- Defined concentration range<\/li>\n\n\n\n
- Material lot traceability<\/li>\n\n\n\n
- Mixing instructions<\/li>\n\n\n\n
- Molding parameters<\/li>\n\n\n\n
- Sterilization conditions<\/li>\n\n\n\n
- Color acceptance limits<\/li>\n\n\n\n
- Retained golden sample<\/li>\n\n\n\n
- Instrumental color measurement<\/li>\n\n\n\n
- Documented change approval<\/li>\n<\/ul>\n\n\n\n
Changes that may require assessment or revalidation include:<\/p>\n\n\n\n
- \n
- Pigment supplier change<\/li>\n\n\n\n
- Pigment-manufacturing-site change<\/li>\n\n\n\n
- Carrier formulation change<\/li>\n\n\n\n
- Base LSR change<\/li>\n\n\n\n
- Pigment concentration change<\/li>\n\n\n\n
- New sterilization method<\/li>\n\n\n\n
- Radiation-dose change<\/li>\n\n\n\n
- Molding or post-curing change<\/li>\n\n\n\n
- Device geometry change<\/li>\n\n\n\n
- New target market<\/li>\n<\/ul>\n\n\n\n
Even when the visible color appears unchanged, a formulation change may affect the chemical or biological profile.<\/p>\n\n\n\n
Establishing Color Acceptance Criteria<\/h1>\n\n\n\n
Color approval should combine visual and instrumental evaluation.<\/p>\n\n\n\n
Common control methods include:<\/p>\n\n\n\n
- \n
- Approved physical golden sample<\/li>\n\n\n\n
- L*, a* and b* values<\/li>\n\n\n\n
- Delta E tolerance<\/li>\n\n\n\n
- D65 light source<\/li>\n\n\n\n
- Defined observation angle<\/li>\n\n\n\n
- Neutral inspection background<\/li>\n\n\n\n
- Surface-finish specification<\/li>\n\n\n\n
- Transparency or haze specification<\/li>\n\n\n\n
- Pre- and post-sterilization limits<\/li>\n<\/ul>\n\n\n\n
Acceptance criteria should be based on the product\u2019s function.<\/p>\n\n\n\n
A decorative external component may allow a wider color tolerance than a color-coded connector used to distinguish device sizes.<\/p>\n\n\n\n
The limit should be agreed upon before mass production instead of being decided after variation occurs.<\/p>\n\n\n\n
Typowe b\u0142\u0119dy przy doborze pigment\u00f3w<\/h1>\n\n\n\n
Selecting by Pantone Number Alone<\/h2>\n\n\n\n
Pantone references are generally printed color standards. Silicone is a three-dimensional material with different gloss, transparency and light-transmission properties.<\/p>\n\n\n\n
A Pantone number should be treated as an initial target, followed by approval of a molded sample.<\/p>\n\n\n\n
Approving Only the Raw Color Paste<\/h2>\n\n\n\n
The pigment masterbatch may look different after mixing, molding, curing, post-curing and sterilization.<\/p>\n\n\n\n
Approval should be based on representative molded components.<\/p>\n\n\n\n
Relying Only on a Supplier\u2019s \u201cMedical Grade\u201d Statement<\/h2>\n\n\n\n
The term does not replace application-specific risk assessment, biological evaluation or regulatory review.<\/p>\n\n\n\n
Ignoring the Pigment Carrier<\/h2>\n\n\n\n
The carrier is part of the colored formulation and should be included in the material assessment.<\/p>\n\n\n\n
Skipping Sterilization Testing<\/h2>\n\n\n\n
A pre-sterilization match does not guarantee post-sterilization stability.<\/p>\n\n\n\n
Changing Suppliers Without Revalidation<\/h2>\n\n\n\n
Two pigments with the same visual shade may have different chemistries, impurity profiles and sterilization behavior.<\/p>\n\n\n\n
Using Consumer-Grade Color Paste for Prototype Samples<\/h2>\n\n\n\n
Early prototype materials can influence customer expectations. Switching to a medically supported pigment later may make the approved color difficult to reproduce.<\/p>\n\n\n\n
\n\n\n\nRecommended Pigment Selection Workflow<\/h1>\n\n\n\n
A practical workflow can be divided into nine stages.<\/p>\n\n\n\n
Stage 1: Define the Device Application<\/h2>\n\n\n\n
Potwierd\u017a:<\/p>\n\n\n\n
- \n
- Device function<\/li>\n\n\n\n
- Patient-contact type<\/li>\n\n\n\n
- Czas trwania kontaktu<\/li>\n\n\n\n
- Target markets<\/li>\n\n\n\n
- Proces sterylizacji<\/li>\n\n\n\n
- Reusable or single-use status<\/li>\n<\/ul>\n\n\n\n
Stage 2: Define the Color Requirement<\/h2>\n\n\n\n
Potwierd\u017a:<\/p>\n\n\n\n
- \n
- Pantone, RAL or physical standard<\/li>\n\n\n\n
- Transparent, translucent or opaque appearance<\/li>\n\n\n\n
- Wyko\u0144czenie powierzchni<\/li>\n\n\n\n
- Grubo\u015b\u0107 \u015bcianki produktu<\/li>\n\n\n\n
- Functional color-coding requirements<\/li>\n<\/ul>\n\n\n\n
Stage 3: Prequalify Pigment Suppliers<\/h2>\n\n\n\n
Review:<\/p>\n\n\n\n
- \n
- Medical-use experience<\/li>\n\n\n\n
- Documentation availability<\/li>\n\n\n\n
- Traceability<\/li>\n\n\n\n
- Change-notification practices<\/li>\n\n\n\n
- Regulatory support<\/li>\n<\/ul>\n\n\n\n
Stage 4: Review Composition and Risk Information<\/h2>\n\n\n\n
Evaluate:<\/p>\n\n\n\n
- \n
- Chemia pigment\u00f3w<\/li>\n\n\n\n
- Carrier system<\/li>\n\n\n\n
- Restricted substances<\/li>\n\n\n\n
- Heavy-metal data<\/li>\n\n\n\n
- Available biological-test information<\/li>\n<\/ul>\n\n\n\n
Stage 5: Develop Laboratory Formulations<\/h2>\n\n\n\n
Prepare multiple concentration levels and mold representative plaques or components.<\/p>\n\n\n\n
Stage 6: Evaluate Processing Performance<\/h2>\n\n\n\n
Potwierd\u017a:<\/p>\n\n\n\n
- \n
- Dispersion<\/li>\n\n\n\n
- Zachowanie zwi\u0105zane z wyleczeniem<\/li>\n\n\n\n
- Wygl\u0105d powierzchni<\/li>\n\n\n\n
- W\u0142a\u015bciwo\u015bci mechaniczne<\/li>\n\n\n\n
- Moldability<\/li>\n<\/ul>\n\n\n\n
Stage 7: Test Sterilization Stability<\/h2>\n\n\n\n
Use the intended EO, gamma, steam or other validated sterilization process.<\/p>\n\n\n\n
Stage 8: Complete Biological and Chemical Evaluation<\/h2>\n\n\n\n
Assess the finished colored formulation according to the medical-device risk-management plan.<\/p>\n\n\n\n
Stage 9: Approve and Lock the Production Formula<\/h2>\n\n\n\n
Establish:<\/p>\n\n\n\n
- \n
- Golden sample<\/li>\n\n\n\n
- Formula number<\/li>\n\n\n\n
- Supplier and material codes<\/li>\n\n\n\n
- Warto\u015bci graniczne kontroli<\/li>\n\n\n\n
- Change-control requirements<\/li>\n\n\n\n
- Traceability records<\/li>\n<\/ul>\n\n\n\n
\n\n\n\nMedical LSR Pigment RFQ Checklist<\/h1>\n\n\n\n
To receive an accurate pigment and molding recommendation, provide the following information:<\/p>\n\n\n\n
- \n
- Medical-device application<\/li>\n\n\n\n
- Part drawing or 3D model<\/li>\n\n\n\n
- Type of body contact<\/li>\n\n\n\n
- Czas trwania kontaktu<\/li>\n\n\n\n
- Silicone grade<\/li>\n\n\n\n
- Wymagania dotycz\u0105ce twardo\u015bci<\/li>\n\n\n\n
- Transparent, translucent or opaque appearance<\/li>\n\n\n\n
- Pantone, RAL or physical color sample<\/li>\n\n\n\n
- Grubo\u015b\u0107 \u015bcianki produktu<\/li>\n\n\n\n
- Tekstura powierzchni<\/li>\n\n\n\n
- Metoda sterylizacji<\/li>\n\n\n\n
- Sterilization dose or cycle<\/li>\n\n\n\n
- Number of reusable cycles<\/li>\n\n\n\n
- Target markets<\/li>\n\n\n\n
- Required biological evaluation<\/li>\n\n\n\n
- Restricted-substance requirements<\/li>\n\n\n\n
- Annual volume<\/li>\n\n\n\n
- Prototype quantity<\/li>\n\n\n\n
- Wymagania dotycz\u0105ce opakowa\u0144<\/li>\n\n\n\n
- Color measurement tolerance<\/li>\n\n\n\n
- Required quality documents<\/li>\n<\/ul>\n\n\n\n
A detailed RFQ helps the molding supplier identify pigment risks before tooling and validation expenses are incurred.<\/p>\n\n\n\n
\n\n\n\nNajcz\u0119\u015bciej zadawane pytania<\/h1>\n\n\n\n
What is a medical-grade LSR pigment?<\/h2>\n\n\n\n
It is generally a pigment or color masterbatch formulated and documented for use in medical silicone applications. However, the term alone does not establish suitability for every device. The complete finished formulation must still be evaluated according to its intended use.<\/p>\n\n\n\n
Does an ISO 10993 report mean the pigment is approved for all medical devices?<\/h2>\n\n\n\n
No. The report applies to the tested material, concentration, extraction conditions and endpoints. Device-specific biological evaluation is still required.<\/p>\n\n\n\n
Can food-grade silicone pigments be used in medical LSR?<\/h2>\n\n\n\n
Food-contact documentation does not automatically demonstrate medical-device suitability. Medical applications may require different chemical, biological and regulatory evidence.<\/p>\n\n\n\n
Which pigments are best for gamma sterilization?<\/h2>\n\n\n\n
There is no universal pigment family that performs best in every color and formulation. Candidate pigments should be screened at the intended radiation dose and evaluated immediately and after storage.<\/p>\n\n\n\n
Can the same pigment be used for EO and steam sterilization?<\/h2>\n\n\n\n
Possibly, but performance should be validated under both processes. Steam introduces higher thermal and moisture stress than EO.<\/p>\n\n\n\n
Does pigment affect LSR curing?<\/h2>\n\n\n\n
Certain pigments, carriers, impurities or excessive concentrations can influence cure behavior. Cure testing should be included during formulation development.<\/p>\n\n\n\n
Why does the molded color differ from the Pantone card?<\/h2>\n\n\n\n
Silicone transparency, thickness, surface texture and lighting affect visual appearance. Pantone cards are printed references and cannot perfectly represent molded silicone.<\/p>\n\n\n\n
Should transparent medical LSR use less pigment?<\/h2>\n\n\n\n
Transparent formulations normally require carefully controlled, relatively low pigment levels, but the correct concentration depends on color strength, wall thickness and transparency requirements.<\/p>\n\n\n\n
Is a Certificate of Analysis required for every pigment batch?<\/h2>\n\n\n\n
This depends on the manufacturer\u2019s quality system and risk controls, but lot-specific documentation and traceability are strongly recommended for medical production.<\/p>\n\n\n\n
When should a colored LSR formulation be revalidated?<\/h2>\n\n\n\n
Revalidation or documented assessment may be needed after changes to the pigment, carrier, supplier, silicone grade, concentration, processing conditions, sterilization method or device design.<\/p>\n\n\n\n
\n\n\n\nWnioski<\/h1>\n\n\n\n
Choosing pigments for medical LSR requires more than achieving an attractive and accurate color.<\/p>\n\n\n\n
The selected pigment system must be compatible with the silicone, stable during molding and sterilization, supported by appropriate safety information and controlled through a documented medical-device quality process.<\/p>\n\n\n\n
Successful pigment selection begins with a clear understanding of the device application, patient-contact conditions and intended sterilization method. It continues through supplier qualification, formulation development, chemical and biological assessment, representative molding trials and post-sterilization evaluation.<\/p>\n\n\n\n
Manufacturers should avoid relying solely on broad terms such as \u201cmedical grade,\u201d \u201cFDA compliant\u201d or \u201cbiocompatible.\u201d These statements must be supported by documentation that is relevant to the specific formulation and intended device.<\/p>\n\n\n\n
By treating the pigment, carrier, silicone base, molding process and sterilization cycle as one complete material system, medical-device companies can achieve safer products, more consistent colors and a more efficient path from prototype development to validated mass production.<\/p>","protected":false},"excerpt":{"rendered":"
Selecting a pigment for medical liquid silicone rubber is not simply a matter of finding the closest Pantone color. The selected pigment system can affect the biological evaluation, chemical profile, sterilization stability, appearance and long-term consistency of the finished medical device. A pigment that performs well in a consumer silicone product may not provide the […]<\/p>\n","protected":false},"author":1,"featured_media":2594,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[33],"tags":[2221,2220,2008,2218,2009,2219,2222,1951,2217],"class_list":["post-2593","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technical-guides","tag-biocompatible-silicone-color","tag-lsr-color-matching","tag-medical-device-silicone","tag-medical-grade-silicone-pigment","tag-medical-liquid-silicone-rubber","tag-medical-lsr-pigments","tag-medical-silicone-colorants","tag-medical-silicone-molding","tag-sterilization-resistant-pigment"],"_links":{"self":[{"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/posts\/2593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/comments?post=2593"}],"version-history":[{"count":1,"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/posts\/2593\/revisions"}],"predecessor-version":[{"id":2595,"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/posts\/2593\/revisions\/2595"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/media\/2594"}],"wp:attachment":[{"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/media?parent=2593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/categories?post=2593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fhysilicone.com\/pl\/wp-json\/wp\/v2\/tags?post=2593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}